| Contributors: |
Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg); Hôpitaux Universitaires de Strasbourg (HUS); Université de Strasbourg (UNISTRA); Nouvel Hôpital Civil de Strasbourg; Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP); Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Toulouse (EPE UT); Communauté d'universités et établissements de Toulouse (Comue de Toulouse)-Communauté d'universités et établissements de Toulouse (Comue de Toulouse); Centre Hospitalier Universitaire de Toulouse (CHU Toulouse); Aix Marseille Université (AMU); Mediterranean Association for Research and Studies in Cardiology (MARS cardio); Hôpital Nord CHU - APHM; Physiologie & médecine expérimentale du Cœur et des Muscles U 1046 (PhyMedExp); Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM); Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier); Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy); Institut Mondor de Recherche Biomédicale (IMRB); Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12); Hôpital Henri Mondor; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Henri Mondor Créteil; Groupe Henri Mondor-Albert Chenevier-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Henri Mondor-Albert Chenevier-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12); Clinique Ambroise Paré - ELSAN (CAPE); Médecine Intensive-Réanimation CHU Amiens; CHU Amiens-Picardie; Hôpital Européen Georges Pompidou APHP (HEGP); Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO); Université Paris Descartes - Paris 5 (UPD5); Centre hospitalier de Dieppe; Centre hospitalier Bretagne Atlantique (Morbihan) (CHBA); Institut des Maladies Métaboliques et Casdiovasculaires (UPS/Inserm U1297 - I2MC); Hôpital Louis Pasteur Chartres; CHU Saint-Antoine AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU); Centre hospitalier régional de Metz-Thionville (CHR Metz-Thionville); Laboratoire Traitement du Signal et de l'Image (LTSI); Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM); Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Pontchaillou; Centre de recherche Cardio-Thoracique de Bordeaux Bordeaux (CRCTB); Université de Bordeaux (UB)-Centre Hospitalier Universitaire de Bordeaux (CHU Bordeaux)-Institut National de la Santé et de la Recherche Médicale (INSERM); Hôpital Haut-Lévêque CHU Bordeaux; Centre Hospitalier Universitaire de Bordeaux (CHU Bordeaux); Hospices Civils de Lyon (HCL); Université Pierre et Marie Curie - Paris 6 (UPMC); The study was sponsored by the Fédération Française de Cardiologie and was funded by unrestricted grants from Daiichi-Sankyo and Maquet SAS.; FRENSHOCK Investigators: Nadia Aissaoui, François Bagate, Marion Beuzelin, Caroline Biendel, Florence Boissier, Laurent Bonello, Éric Bonnefoy-Cudraz, Marie Boughenou, Stéphane Boule, Jérémie Bourenne, Nicolas Brechot, Cédric Bruel, Alain Cariou, Philippe Castellant, Sébastien Champion, Karim Chaoui, Marion Chatot, Nicolas Combaret, Nicolas Debry, Xavier Delabranche, Jean-Claude Dib, Raphael Favory, Emmanuelle Filippi, Romain Gallet, Frédérique Ganster, Philippe Gaudard, Edouard Gerbaud, Brahim Harbaoui, Patrick Henry, Benoit Herce, Fabrice Ivanes, Jérémie Joffre, Philippe Karoubi, Hadi Khachab, Khalifé Khalife, Kada Klouche, Vincent Labbe, Marc Laine, Nicolas Lamblin, Benoit Lattuca, Yann Lefetz, Gilles Lemesle, Philippe Letocart, Leurent, Bruno Levy, Guillaume Louis, Julien Maizel, Jacques Mansourati, Stéphane Manzo-Silberman, Séverine Marchand, Benjamin Marchandot, Stéphanie Marliere, Joy Mootien, Frédéric Mouquet, Louis Niquet, Alexis Paternot, Vincent Probst, Etienne Puymirat, Charlotte Quentin, Grégoire Range, Nassim Redjimi, Jean Christophe Richard, François Roubille, Christophe Saint Etienne, Francis Schneider, Guillaume Schurtz, Marie-France Seronde, Julien Ternacle, Gérald Vanzetto, Elie Zogheib |
| Description: |
International audience ; Aim: Differences between cardiogenic shock (CS) with and without prior resuscitated cardiac arrest (CA) remain largely unexplored. We hypothesized that patients who experience shockable CA followed by CS are likely to have worse outcomes compared to CS without prior CA.Methods: FRENSHOCK is a prospective multicenter observational registry conducted in French critical care units in 2016, which included CS from various etiologies. Patients admitted after resuscitation of a CA were included if they fulfilled previously defined CS criteria. Non-shockable rhythms at the time of medical intervention were considered exclusion criteria and were not recorded in the registry.Results: Among the 771 enrolled patients (mean age 65.7 ± 14.9 years; 71.5 % male), 79 (10.2 %) had a resuscitated shockable cardiac arrest just before inclusion. Shockable CA patients had more respiratory support (78.5 % vs. 33.2 %, p < 0.001), more mechanical circulatory support (35.4 % vs. 16.5 %, p < 0.001), more coronary angiography performed (76 % vs. 48.8 %, p < 0.001), finding more mono-troncular lesions (39 % vs. 16.9 %, p < 0.001). Thirty-day and one-year survival were similar between groups. Among 30-day survivors, CS with an initial shockable CA exhibited significantly improved long-term survival compared to CS without prior resuscitated CA.Conclusion: In a cohort of patients with cardiogenic shock from various etiologies, approximately 10% had experienced prior resuscitation following a cardiac arrest with shockable rhythms. Our findings suggest that selected cardiac arrest with a shockable rhythm leading to cardiogenic shock does not inherently confer a worse prognosis compared to other causes of cardiogenic shock. |